What is NDC 51662-1553?

51662-1553 is the product NDC for LIDOCAINE HCl, Lidocaine hydrochloride 40 mg/mL solution, listed with the FDA by HF Acquisition Co LLC, DBA HealthFirst. It has 1 package NDC, shown above in 10- and 11-digit form.

HF Acquisition Co LLC, DBA HealthFirst, NDC labeler code 51662. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for LIDOCAINE HCl?

6 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

LIDOCAINE HCl NDC 51662-1553 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)51662-1553Labeler and product segments. Claims need a package NDC.

Product NDC at billing width51662-1553Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
51662-1553-3	5166215530351662155303	25 POUCH in 1 CASE (51662-1553-3) / 1 VIAL in 1 POUCH (51662-1553-2) / 4 mL in 1 VIALMarketed from Jun 14, 2021

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): LIDOCAINE HCl
Generic name (nonproprietary): lidocaine hcl
Active ingredients: Lidocaine hydrochloride — 40 mg/mL
Dosage form: Solution
Route: Topical
Labeler: HF Acquisition Co LLC, DBA HealthFirstNDC labeler code 51662
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 086364
Marketing start: Jun 14, 2021
Listing expires: Dec 31, 2026
Other FDA classes: Amides (Chemical structure)Local Anesthesia (Physiologic effect)
Identifiers: Product ID 51662-1553_100cb889-1a7b-6252-e063-6394a90a9221SPL ID 100cb889-1a7b-6252-e063-6394a90a9221SPL set ID c4c16714-6b1f-857e-e053-2a95a90a74e4RxCUI 1010878UNII V13007Z41A
Pharmacologic class: Amide Local Anesthetic; Antiarrhythmic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N451662155303 followed by a unit qualifier and the quantity

Package 51662-1553-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 28, 2024.

Indications (excerpt from the label)

INDICATIONS & USAGE Lidocaine HCI Topical Solution, 4% is indicated for the production of topical anesthesia of the mucous membranes of the respiratory tract.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 51662-1553

What is NDC 51662-1553?: 51662-1553 is the product NDC for LIDOCAINE HCl, Lidocaine hydrochloride 40 mg/mL solution, listed with the FDA by HF Acquisition Co LLC, DBA HealthFirst. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: LIDOCAINE HCl.
What is the active ingredient?: Lidocaine hydrochloride.
Who is the labeler?: HF Acquisition Co LLC, DBA HealthFirst, NDC labeler code 51662. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for LIDOCAINE HCl?: 6 other product NDCs are listed under this name. See all LIDOCAINE HCl NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other LIDOCAINE HCl NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Lidocaine HCl	Lidocaine hydrochloride anhydrous 5 mg/g	GelTopical	Topco Associates LLC	76162-034	76162-0034-34
Lidocaine HCL	Lidocaine hydrochloride 4 g/100g	CreamTopical	Matthias Therapeutics, LLC	87137-101	87137-0101-07
LIDOCAINE HCl	Lidocaine hydrochloride 40 mg/mL	Injection, SolutionRetrobulbar, Topical, Transtracheal	HF Acquisition Co LLC, DBA HealthFirst	51662-1596	51662-1596-03
LIDOCAINE HCl	Lidocaine hydrochloride 10 mg/mL	Injection, SolutionEpidural, Infiltration, Intracaudal, Perineural	HF Acquisition Co LLC, DBA HealthFirst	51662-1593	51662-1593-03
LIDOCAINE HCl	Lidocaine hydrochloride 10 mg/mL	Injection, SolutionEpidural, Infiltration, Intracaudal, Perineural	HF Acquisition Co LLC, DBA HealthFirst	51662-1538	51662-1538-0151662-1538-03
LIDOCAINE HCl	Lidocaine hydrochloride 10 mg/mL	Injection, SolutionEpidural, Infiltration, Intracaudal	HF Acquisition Co LLC, DBA HealthFirst	51662-1438	51662-1438-0151662-1438-03

Other NDCs under ANDA 086364

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 086364
Product	Strength	Form · route	Labeler	Product NDC
Lidocaine Hydrochloride	Lidocaine hydrochloride 40 mg/mL	SolutionTopical	International Medication Systems, Limited	76329-6300